Cumberland Pharmaceuticals (CPIX) Current Assets (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Current Assets of $32.8 million for Q1 2026, down 11.52% sequentially from $37.1 million in Q4 2025, and up 2.86% YoY from $31.9 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Current Assets (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Current Assets for 17 years, with the latest figure at $32.8 million in Q1 2026.
- Quarterly Current Assets rose 2.86% year-over-year to $32.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.8 million (up 2.86% YoY) and the FY2025 annual result came in at $37.1 million, up 1.67% from the prior year.
- Current Assets declined to $32.8 million in Q1 2026 per CPIX's latest filing, from $37.1 million in the prior quarter.
- Over five years, Current Assets peaked at $49.2 million in Q3 2022 and troughed at $29.9 million in Q3 2025.
- A 5-year average of $38.6 million and a median of $36.5 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2023: Current Assets gained 4.12% in 2022, then dropped 22.14% in 2023.
- Over 5 years, Current Assets stood at $45.9 million in 2022, then decreased by 22.14% to $35.7 million in 2023, then increased by 2.07% to $36.5 million in 2024, then gained by 1.67% to $37.1 million in 2025, then decreased by 11.52% to $32.8 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $32.8 million, $37.1 million, and $29.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | 33.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.64 Mn |
| Mar 31, 2026 | 32.79 Mn |
| Dec 31, 2025 | 37.06 Mn |
| Sep 30, 2025 | 29.94 Mn |
| Jun 30, 2025 | 31.21 Mn |
| Mar 31, 2025 | 31.88 Mn |
| Dec 31, 2024 | 36.45 Mn |
| Sep 30, 2024 | 35.24 Mn |
| Jun 30, 2024 | 35.58 Mn |
| Mar 31, 2024 | 36.21 Mn |
| Dec 31, 2023 | 35.71 Mn |
| Sep 30, 2023 | 41.77 Mn |
| Jun 30, 2023 | 43.67 Mn |
| Mar 31, 2023 | 43.81 Mn |
| Dec 31, 2022 | 45.87 Mn |
| Sep 30, 2022 | 49.16 Mn |
| Jun 30, 2022 | 43.75 Mn |
| Mar 31, 2022 | 45.34 Mn |
| Dec 31, 2021 | 45.69 Mn |
| Sep 30, 2021 | 47.22 Mn |